Sun Nuclear to Showcase Next-Generation Quality Assurance and AI Innovations at AAPM & COMP 2026
Sun Nuclear, a Mirion Medical company specializing in quality management solutions for radiation therapy and diagnostic imaging, has announced the technologies it will showcase at the 2026 American Association of Physicists in Medicine (AAPM) and Canadian Organization of Medical Physicists (COMP) Annual Meeting, taking place July 19–21 in Vancouver, Canada.
Under the theme “Next-Gen Innovations for Next-Level Physics,” the company will present a range of advanced quality assurance (QA), adaptive radiotherapy, and artificial intelligence-powered treatment planning solutions designed to help medical physics teams improve efficiency, accuracy, and patient care.
Visitors to Booth 800 will have the opportunity to explore live demonstrations of Sun Nuclear’s newest technologies, attend presentations led by leading clinical experts, and participate in a dedicated lunch symposium highlighting emerging trends in medical physics and radiation therapy.
Advancing Quality Assurance for Modern Radiation Therapy
As radiation therapy technologies become increasingly sophisticated, healthcare providers are seeking quality assurance tools that simplify workflows while maintaining the highest standards of precision and patient safety.
Sun Nuclear’s latest innovations are intended to address these evolving clinical requirements by reducing operational complexity, automating repetitive tasks, and supporting more efficient treatment planning and machine verification.
The company believes that by combining intelligent software with integrated hardware solutions, medical physics teams can devote more time to patient-focused activities while maintaining confidence in every stage of the treatment process.
This year’s exhibition emphasizes practical technologies that fit seamlessly into existing clinical workflows while preparing cancer centers for the next generation of precision radiation therapy.
Daily QA 4 Pro Simplifies Machine Quality Assurance
One of the centerpiece technologies at the exhibition will be Daily QA™ 4 Pro, Sun Nuclear’s newest quality assurance solution designed to modernize routine machine verification.
Traditionally, daily QA procedures often require multiple devices, repeated room entries, and several setup steps to complete dosimetric and imaging evaluations. Daily QA 4 Pro addresses these challenges by integrating multiple verification tasks into a single, imageable, indexed device.
The unified approach allows clinical teams to perform dosimetry measurements and imaging quality checks using one system, significantly simplifying the daily quality assurance process.
By reducing the number of individual procedures required during equipment verification, the solution helps minimize setup time, decrease room access requirements, and promote standardized workflows among different users.
Integration with the SunCHECK Platform
Daily QA 4 Pro is fully integrated with the SunCHECK® Platform, allowing quality assurance data to be analyzed automatically while generating comprehensive reports with minimal manual intervention.
The integration enables healthcare providers to streamline documentation, reduce administrative workload, and improve consistency across routine QA procedures.
Automation also supports faster decision-making by providing immediate access to performance data, allowing medical physicists to quickly identify trends or potential issues before they affect patient treatments.
According to Sun Nuclear, this combination of hardware integration and intelligent software enables clinical teams to spend less time managing quality assurance logistics and more time focusing on patient care and treatment optimization.
Clinical Experts Share Real-World Experience
The company will feature presentations from leading medical physicists who have implemented Daily QA 4 Pro in clinical environments.
Maria Bellon, M.S., DABR, from Cedars-Sinai Medical Center, and David Barbee, Ph.D., from NYU Langone Health, will discuss their firsthand experiences using the system and explain how the technology has influenced quality assurance workflows within their respective organizations.
Their presentations will provide attendees with practical insights into implementation strategies, workflow improvements, and the clinical benefits associated with adopting more integrated machine QA solutions.
Artificial Intelligence Supports Smarter Treatment Planning
Artificial intelligence continues to play an increasingly important role in radiation oncology, particularly in treatment planning.
Sun Nuclear will highlight Plan AI™, an AI-assisted treatment planning solution designed to help dosimetrists develop high-quality, patient-specific treatment plans more efficiently.
The platform leverages FDA-cleared artificial intelligence models capable of predicting dose-volume outcomes before treatment planning begins.
By providing clinicians with predictive guidance early in the planning process, Plan AI helps identify optimal treatment strategies while reducing unnecessary planning iterations.
The result is a faster, more efficient workflow that supports improved treatment consistency without compromising quality.
Enhancing Workflow and Peer Review
Beyond accelerating plan development, Plan AI also strengthens the peer review process.
Early prediction of treatment outcomes enables clinicians to evaluate planning objectives before extensive optimization begins, allowing teams to identify potential improvements sooner.
This proactive approach supports better collaboration among dosimetrists, radiation oncologists, and medical physicists while helping organizations maintain high clinical standards across treatment planning activities.
By reducing manual trial-and-error processes, Plan AI contributes to more streamlined operations while enabling healthcare providers to deliver personalized radiation therapy with greater confidence.
Johns Hopkins Expert Discusses AI in Clinical Practice
Professor Todd McNutt, M.S., Ph.D., Director of Clinical Informatics at Johns Hopkins, will share his experience incorporating artificial intelligence into radiation therapy workflows.
Professor McNutt will present during both Sun Nuclear’s Sunday lunch symposium and an additional in-booth educational session scheduled for Monday.
His presentations will examine how AI-powered planning technologies are transforming clinical practice, improving planning efficiency, and supporting higher-quality treatment decisions across radiation oncology departments.
Attendees will gain valuable insight into how predictive artificial intelligence can complement the expertise of clinical teams rather than replace it, ultimately helping providers deliver more personalized patient care.
AdaptCHECK Supports Adaptive Radiotherapy
Adaptive radiotherapy continues to gain momentum as cancer centers increasingly tailor treatments based on changes in patient anatomy throughout the treatment course.
As online adaptive treatment becomes more widely adopted, independent plan verification has become increasingly important to ensure treatment accuracy and patient safety.
To address this need, Sun Nuclear will showcase AdaptCHECK™, a solution specifically developed for independent verification of adaptive radiation therapy plans.
The platform provides clinicians with additional confidence by independently validating treatment plans before delivery, helping reduce risk while supporting safe implementation of adaptive workflows.
Clinical users will present real-world experiences with AdaptCHECK during dedicated educational sessions held throughout the exhibition.
These discussions will demonstrate how independent verification contributes to efficient adaptive radiotherapy while maintaining rigorous quality assurance standards.
Educational Symposium Highlights Emerging Technologies
Sun Nuclear will also host a dedicated Lunch Symposium on Sunday, July 19, at 12:15 p.m. in the Innovation Room.
The educational program will focus on the company’s latest product innovations, including Daily QA 4 Pro, Plan AI, and AdaptCHECK.
Attendees will hear directly from clinical experts and company specialists about the practical applications of these technologies and their potential impact on modern radiation therapy.
Because seating is limited, participants are encouraged to register in advance through Sun Nuclear’s event website.
Leadership Perspective
Luis Rivera, Executive Vice President for Mirion Medical, emphasized the company’s commitment to supporting the evolving needs of medical physics professionals.
According to Rivera, Sun Nuclear continues investing in next-generation technologies that enable healthcare providers to achieve higher levels of precision, operational excellence, and patient safety.
He noted that the innovations being introduced at the AAPM & COMP Annual Meeting reflect the company’s long-term vision of transforming radiation therapy through smarter quality management, advanced automation, and clinically meaningful artificial intelligence.
Rivera added that by equipping physics teams with practical tools that simplify complex workflows, Sun Nuclear aims to help healthcare organizations improve both clinical performance and patient outcomes.
Live Demonstrations Throughout the Meeting
Visitors to Booth 800 will have opportunities to participate in live demonstrations of all featured technologies throughout the conference.
Company specialists will be available to explain product capabilities, answer technical questions, and demonstrate how the solutions integrate into existing clinical environments.
Attendees can also pre-schedule personalized demonstrations or reserve seats for educational presentations before the conference begins.
About Sun Nuclear
Sun Nuclear is part of Mirion Medical, a healthcare-focused division of Mirion Technologies dedicated to advancing radiation therapy and diagnostic imaging through innovative quality management solutions.
The company serves more than 6,000 cancer treatment centers worldwide, providing independent, integrated quality assurance technologies that support safe and effective radiation therapy.
Its product portfolio includes solutions for machine quality assurance, patient safety, treatment planning verification, adaptive therapy, and workflow automation.
Beyond technology development, Sun Nuclear places strong emphasis on customer support, clinical education, and successful technology adoption, helping healthcare organizations maximize the value of their quality management investments.
By simplifying complex clinical processes and improving operational efficiency, the company seeks to enable healthcare professionals to focus on what matters most—delivering safe, accurate, and effective cancer treatment for every patient.
As medical physics continues evolving through advances in automation, adaptive therapy, and artificial intelligence, Sun Nuclear’s latest innovations demonstrate its commitment to helping clinics embrace the future of radiation oncology while maintaining the highest standards of quality, precision, and patient care.
Source link: https://www.businesswire.com